# Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene

> **NCT00847821** · — · TERMINATED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 185 (actual)

## Conditions studied

- Postmenopause

## Interventions

- **DRUG:** Bazedoxifene 10 mg/CE 0.625 mg
- **DRUG:** Bazedoxifene 20 mg/CE 0.625 mg
- **DRUG:** Bazedoxifene 40 mg/CE 0.625 mg
- **DRUG:** Bazedoxifene 10 mg/CE 0.45 mg
- **DRUG:** Bazedoxifene 20 mg/CE 0.45 mg
- **DRUG:** Bazedoxifene 40 mg/CE 0.45 mg
- **DRUG:** Raloxifene 60 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00847821
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 185 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2010-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847821, "Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00847821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*